Men beware!

Editorial note: The following is an anonymous commentary that has been posted twice to this web site in recent days. Parts of it are factually accurate. Some of it is certainly factually inaccurate. Most of it appears to refer to the situation here in America. And a lot of it is personal opinion (as the author states). … READ MORE …

Mirror, mirror, on the wall, …

For years, physicians and their patients diagnosed with low-risk prostate cancer believed that those patients were at high risk for progressive disease over time. And physicians and their patients diagnosed with a form of breast cancer known as ductal carcinoma in situ or DCIS had similar beliefs. … READ MORE …

Over-treatment of older men with life expectancies < 10 years

According to a paper newly published in Cancer, “Men aged < 80 years at diagnosis who have life expectancies < 10 years often receive aggressive treatment for low-risk and intermediate-risk prostate cancer, mostly with radiation therapy.” … READ MORE …

Can we accurately project risk for over-diagnosis and over-treatment?

There is an interesting new article just published in the Journal of the National Cancer Institute describing a nomogram designed to estimate risk for over-diagnosis of men diagnosed with prostate cancer. … READ MORE …

Screening and its consequences: an interview with Laura Esserman

Yesterday, Medscape Oncology published a brief interview with Dr. Laura Esserman (under the title “Cancer screening: when less is more“) that will be of interest to a number of our regular readers. … READ MORE …

The over-treatment of low-risk disease in the Medicare community

So there’s a lot of media coverage this morning about an article in the Journal of the American Medical Association suggesting that, here in the USA, more men with low-risk forms of localized prostate cancer are getting more expensive types of treatment for their cancer (and that much of this treatment may be of dubious value). … READ MORE …

Over-diagnosis, over-treatment, and “first, do no harm”

The potential problems associated with over-diagnosis and over-treatment that have been much debated in the world of prostate cancer over the past few years actually go well beyond prostate cancer. … READ MORE ..